Topic 15 — Macrolides, Linezolid, Clindamycin, Streptogramins and Chloramphenicol

3rd Year MBBS • Infection and Inflammation

A rapid revision view connecting ribosomal targets, antibacterial use, pharmacokinetics and major toxicities.

1. THE TOPIC IN ONE CONNECTED FLOW

These drugs mainly suppress bacterial protein synthesis by acting at the 50S ribosomal subunit, but each class interferes with a different step. Their clinical usefulness therefore depends not only on the ribosomal target, but also on spectrum, tissue distribution, resistance and characteristic toxicity.

50S Ribosomal Target
Bacterial protein synthesis

→

Different Drug Actions
Translocation, initiation or peptide-bond formation inhibited

→

Reduced Protein Synthesis
Growth of susceptible bacteria is inhibited

→

Clinical Selection
Spectrum + tissue penetration + resistance pattern

→

Key Safety Check
Interactions and characteristic adverse effects

Macrolides
23S rRNA on 50S → impaired translocation → useful in susceptible respiratory and atypical infections.

Linezolid
50S binding → failure of functional 70S initiation complex → activity against MRSA and VRE.

Clindamycin
50S inhibition → reduced peptide-chain elongation → useful in susceptible anaerobic and gram-positive infections.

Streptogramins
Quinupristin + dalfopristin → synergistic 50S inhibition → selected resistant gram-positive infections.

Chloramphenicol
50S peptidyl transferase inhibition → broad activity, but systemic use limited by serious toxicity.

2. KEY CLINICAL CONNECTIONS

Macrolide Selection

Atypical respiratory pathogen → good intracellular and tissue penetration → macrolide activity becomes clinically useful.

Azithromycin tissue retention → prolonged antibacterial concentrations → less frequent administration than erythromycin.

Resistant Gram-Positive Infection

MRSA or VRE → linezolid blocks formation of the 70S initiation complex → bacterial translation cannot begin normally.

VRE caused by E. faecium → quinupristin-dalfopristin may be useful → activity is not reliable against E. faecalis.

Toxicity Determines Drug Choice

Clindamycin exposure → suppression of normal intestinal flora → C. difficile overgrowth → toxin-mediated pseudomembranous colitis.

Chloramphenicol exposure → marrow toxicity risk → safer alternatives are preferred for routine systemic treatment.

3. AIM HIGH-YIELD INTEGRATION REVIEW

⭐ Macrolide binding to 23S rRNA on the 50S subunit → impaired translocation → reduced bacterial protein synthesis, especially useful against susceptible respiratory and atypical organisms.

Azithromycin accumulates in tissues and phagocytes → prolonged tissue concentrations → convenient less-frequent dosing compared with erythromycin.

Erythromycin and clarithromycin inhibit CYP3A4 more than azithromycin → greater potential for clinically important metabolic drug interactions.

⭐ Linezolid blocks 70S initiation-complex formation → translation fails to start → important activity against MRSA and vancomycin-resistant enterococci.

⭐ Clindamycin disturbs intestinal flora → C. difficile proliferation and toxin production → pseudomembranous colitis.

Quinupristin-dalfopristin acts synergistically at the 50S ribosome → useful against selected resistant gram-positive organisms, especially vancomycin-resistant E. faecium.

⭐ Chloramphenicol inhibits peptidyl transferase → protein synthesis falls, but severe marrow toxicity limits routine systemic use despite broad antibacterial activity and good CNS penetration.

Neonatal immature glucuronidation and elimination → chloramphenicol accumulation → cardiovascular toxicity and Gray Baby syndrome.

AIM Exam Trap:
Macrolides mainly interfere with translocation, linezolid blocks initiation-complex formation, and chloramphenicol inhibits peptidyl transferase. These 50S mechanisms are related but not interchangeable.